VOYA Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
VOYA Investment Management's XBI Position: Q2 2025 in Review
VOYA Investment Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 227,917 shares — an estimated $18.5M sold.
VOYA Investment Management first reported a position in XBI in Q1 2022 and held it in 13 quarters. The position peaked at $30.3M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.
- VOYA Investment Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
- VOYA Investment Management sold 227,917 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $18.5M.
- VOYA Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and held it in 13 quarters.
- VOYA Investment Management's State Street SPDR S&P Biotech ETF position peaked at $30.3M in Q3 2024.
- 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.
Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.